Frontline Treatment of Chronic Myelogenous Leukemia

1 Views
administrator
administrator
06/27/23

There are currently three agents approved for the frontline treatment of patients with Philadelphia chromosome-positive chronic myelogenous leukemia, making an upfront treatment decision difficult. To address this, panelist explore possible first-line options and nuances of selecting therapies.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mds-cml

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next